Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye

Lin Lin; Yirui Zhu; Kelan Yuan; Yujie Mou; Hanhe Zhao; Yayin Wu; Xiuming Jin

doi:10.1016/j.aopr.2024.01.006

您当前的位置：

首页 >

文章列表页 >

Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye

Letter to the Editor | 更新时间：2024-05-29

- Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye
- AOPR Vol. 4, Issue 2, Pages: 47-51(2024)
- 作者机构：
  
  Eye Center of the Second Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou,China
- 作者简介：
- 基金信息：
- DOI：10.1016/j.aopr.2024.01.006
  CLC：
- Published：2024，
扫描看全文
Lin Lin, Yirui Zhu, Kelan Yuan, et al. Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye. [J]. AOPR 4(2):47-51(2024)
DOI：

Lin Lin, Yirui Zhu, Kelan Yuan, et al. Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye. [J]. AOPR 4(2):47-51(2024) DOI： 10.1016/j.aopr.2024.01.006.

摘要

Abstract

关键词

Keywords

references

1 E.J. Holland, M. Darvish, K.K. Nichols, L. Jones, P.M. KarpeckiEfficacy of topical ophthalmic drugs in the treatment of dry eye disease: a systematic literature review Ocul Surf, 17 (3) (Jul 2019), pp. 412-423, 10.1016/j.jtos.2019.02.012

2 M.M. Hom, A.L. Nguyen, L. BieloryAllergic conjunctivitis and dry eye syndrome Ann Allergy Asthma Immunol, 108 (3) (Mar 2012), pp. 163-166, 10.1016/j.anai.2012.01.006

3 K. Singh, S. Axelrod, L. BieloryThe epidemiology of ocular and nasal allergy in the United States, 1988-1994 J Allergy Clin Immunol, 126 (4) (Oct 2010), pp. 778-783 e6, 10.1016/j.jaci.2010.06.050

4 A.M. IraniOcular mast cells and mediators Immunol Allergy Clin, 28 (1) (Feb 2008), pp. 25-42, 10.1016/j.iac.2007.12.006

5 J.D. Nelson, J.P. Craig, E.K. Akpek, et al.TFOS DEWS II introduction Ocul Surf, 15 (3) (Jul 2017), pp. 269-275, 10.1016/j.jtos.2017.05.005

6 A. Kubicka-Trzaska, B. Romanowska-Dixon[Dry eye syndrome and allergic conjunctivitis-epidemics of XXI century-diagnostic problems and management] Przegl Lek, 66 (11) (2009), pp. 967-971 Zespol suchego oka i alergiczny niezyt spojowek-epidemie XXI wieku-problemy diagnostyczne i leczenie

7 The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye WorkShop Ocul Surf, 5 (2) (2007), pp. 93-107, 10.1016/s1542-0124(12)70082-4 Apr 2007

8 L. Chen, L. Pi, J. Fang, X. Chen, N. Ke, Q. LiuHigh incidence of dry eye in young children with allergic conjunctivitis in Southwest China Acta Ophthalmol, 94 (8) (Dec 2016), pp. e727-e730, 10.1111/aos.13093

9 M.S. Cowlen, V.Z. Zhang, L. Warnock, C.F. Moyer, W.M. Peterson, B.R. YerxaLocalization of ocular P2Y2 receptor gene expression by in situ hybridization Exp Eye Res, 77 (1) (Jul 2003), pp. 77-84, 10.1016/s0014-4835(03)00068-x

10 J.E. Jumblatt, M.M. JumblattRegulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva Exp Eye Res, 67 (3) (Sep 1998), pp. 341-346, 10.1006/exer.1998.0520

11 J. Tauber, W.F. Davitt, J.E. Bokosky, et al.Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye Cornea, 23 (8) (Nov 2004), pp. 784-792, 10.1097/01.ico.0000133993.14768.a9

12 O.C. Lau, C. Samarawickrama, S.E. SkalickyP2Y2 receptor agonists for the treatment of dry eye disease: a review Clin Ophthalmol, 8 (2014), pp. 327-334, 10.2147/OPTH.S39699

13 Z.G. Liu[Paying attention to the expert consensus on dry eye to standardize and promote the clinical diagnosis and treatment of dry eye] Zhonghua Yan Ke Za Zhi, 56 (10) (Oct 11 2020), pp. 726-729, 10.3760/cma.j.cn112142-20200714-00476

14 Cornea Group of Ophthalmology Branch of Chinese Medical A[Chinese expert consensus on keratoprosthesis procedure (2021)] Zhonghua Yan Ke Za Zhi, 57 (10) (Oct 11 2021), pp. 727-733, 10.3760/cma.j.cn112142-20210713-00333

15 L. Bielory, E.O. Meltzer, K.K. Nichols, R. Melton, R.K. Thomas, J.D. BartlettAn algorithm for the management of allergic conjunctivitis Allergy Asthma Proc, 34 (5) (Sep-Oct 2013), pp. 408-420, 10.2500/aap.2013.34.3695

16 L. Lobefalo, E. D'Antonio, L. Colangelo, et al.Dry eye in allergic conjunctivitis: role of inflammatory infiltrate Int J Immunopathol Pharmacol, 12 (3) (Jan-Apr 1999), pp. 133-137

17 S. Gulati, S. JainOcular pharmacology of tear film, dry eye, and allergic conjunctivitis Handb Exp Pharmacol, 242 (2017), pp. 97-118, 10.1007/164_2016_73

18 S. Suzuki, E. Goto, M. Dogru, et al.Tear film lipid layer alterations in allergic conjunctivitis Cornea, 25 (3) (Apr 2006), pp. 277-280, 10.1097/01.ico.0000178277.29010.bc

19 K. Gumus, D.H. CavanaghThe role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca Clin Ophthalmol, 3 (2009), pp. 57-67

20 K.K. Nichols, B. Yerxa, D.J. KellermanDiquafosol tetrasodium: a novel dry eye therapy Expet Opin Invest Drugs, 13 (1) (Jan 2004), pp. 47-54, 10.1517/13543784.13.1.47

21 T. Fujihara, T. Murakami, H. Fujita, M. Nakamura, K. NakataImprovement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model Invest Ophthalmol Vis Sci, 42 (1) (Jan 2001), pp. 96-100

22 T. Murakami, T. Fujihara, M. Nakamura, K. NakataP2Y(2) receptor stimulation increases tear fluid secretion in rabbits Curr Eye Res, 21 (4) (Oct 2000), pp. 782-787, 10.1076/ceyr.21.4.782.5550

23 S. Fukuoka, R. AritaIncrease in tear film lipid layer thickness after instillation of 3% diquafosol ophthalmic solution in healthy human eyes Ocul Surf, 15 (4) (Oct 2017), pp. 730-735, 10.1016/j.jtos.2017.03.005

24 Y. Zhang, Y. Qi, X. Xie, F. ZhangThe effect of 3% diquafosol on the improvement of ocular surface post cataract surgery: a meta-analysis for time of intervention Advances in Ophthalmology Practice and Research, 2 (3) (2022/11/01/2022), Article 100063, 10.1016/j.aopr.2022.100063

25 T. Onguchi, M. Dogru, N. Okada, et al.The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings Am J Ophthalmol, 141 (3) (Mar 2006), pp. 569-571, 10.1016/j.ajo.2005.09.032

26 M. Dogru, N. Asano-Kato, M. Tanaka, et al.Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers Curr Eye Res, 30 (10) (Oct 2005), pp. 897-908, 10.1080/02713680500196715

27 Y. Hu, Y. Matsumoto, M. Dogru, et al.The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis Allergy, 62 (8) (Aug 2007), pp. 917-925, 10.1111/j.1398-9995.2007.01414.x

28 J.P. Craig, K.K. Nichols, E.K. Akpek, et al.TFOS DEWS II definition and classification report Ocul Surf, 15 (3) (Jul 2017), pp. 276-283, 10.1016/j.jtos.2017.05.008

29 K. Tsubota, N. Yokoi, J. Shimazaki, et al.New perspectives on dry eye definition and diagnosis: a consensus report by the asia dry eye society Ocul Surf, 15 (1) (Jan 2017), pp. 65-76, 10.1016/j.jtos.2016.09.003

30 I. Toda, J. Shimazaki, K. TsubotaDry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis Ophthalmology, 102 (2) (Feb 1995), pp. 302-309, 10.1016/s0161-6420(95)31024-x

31 S. Shimazaki-Den, M. Dogru, K. Higa, J. ShimazakiSymptoms, visual function, and mucin expression of eyes with tear film instability Cornea, 32 (9) (Sep 2013), pp. 1211-1218, 10.1097/ICO.0b013e318295a2a5

32 Q. Liang, J. Li, S. Zhang, et al.Characterization of conjunctival microbiome dysbiosis associated with allergic conjunctivitis Allergy, 76 (2) (Feb 2021), pp. 596-600, 10.1111/all.14635

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰